Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients (TELE-TOC)
TELE-TOC: Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
- Other: Virtual at Home Medication Reconciliation Visit(s)
- Behavioral: Virtual At Home Medication Education Visit(s)
- Other: COPD advanced practice nurse Inpatient Consult
- Other: Inpatient Medication Reconciliation
- Other: Post-discharge nurse 48 hour phone follow-up call
- Other: Post-discharge follow-up advanced practice nurse outpatient visit
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Leah Traeger
- Phone Number: 773-834-4489
- Email: ltraeger@bsd.uchicago.edu
Study Contact Backup
- Name: Valerie G Press, MD, MPH
- Phone Number: 7737025170
- Email: vpress@bsd.uchicago.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults 18 years or older
- Admitted to the hospital on a general inpatient ward with a COPD Exacerbation
- Enrolled/seen by our COPD Hospital Readmission Reduction Program
Exclusion Criteria:
- Patients younger than 18 years of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: TELE-TOC plus Usual Care
Patients randomized to this arm will receive the TELE-TOC intervention as well as the standard COPD care via the institution's COPD readmission reduction program.
|
Patients will have their medications reviewed by the TELE-TOC interventionalist, a member of the pharmacy team (anticipated)
Other Names:
Patients will be provided with inhaler education by the TELE-TOC interventionalist, a member of the pharmacy team (anticipated)
Other Names:
Patients will receive a COPD consult by an advanced practice nurse as part of standard of care
Other Names:
Patients will have their medications reviewed by member(s) of the clinical care team as part of standard of care
Patients will receive a post-discharge nurse 48 hour phone follow-up call as part of standard of care
Patients will be scheduled for a 1-2 week post-discharge visit with the COPD advanced practice nurse as part of standard of care
|
|
Active Comparator: Usual Care
Patients randomized to this arm will receive standard COPD care via the institution's COPD readmission reduction program.
|
Patients will receive a COPD consult by an advanced practice nurse as part of standard of care
Other Names:
Patients will have their medications reviewed by member(s) of the clinical care team as part of standard of care
Patients will receive a post-discharge nurse 48 hour phone follow-up call as part of standard of care
Patients will be scheduled for a 1-2 week post-discharge visit with the COPD advanced practice nurse as part of standard of care
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correct inhaler technique 30 days post discharge
Time Frame: 30 days post discharge
|
Correct inhaler technique within 30 days post-discharge compared to baseline technique in hospital based on standardized checklists (<75% correct steps = misuse)
|
30 days post discharge
|
|
Reach of the TELE-TOC intervention
Time Frame: 1-2 weeks post discharge
|
Proportion of patients receiving at home inhaler education within 1-2 weeks post discharge
|
1-2 weeks post discharge
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
30 day revisits
Time Frame: 30 -days
|
proportion of patients with any emergency department visit and/or re-hospitalization within 30 days of index admission
|
30 -days
|
|
90 day revisits
Time Frame: 90 -days
|
proportion of patients with any emergency department visit and/or re-hospitalization within 90 days of index admission
|
90 -days
|
|
180 day revisits
Time Frame: 180 -days
|
proportion of patients with any emergency department visit and/or re-hospitalization within 180 days of index admission
|
180 -days
|
|
Medication errors
Time Frame: Within 30 days
|
Proportion of patients with medication errors at TELE-TOC visit medication reconciliation
|
Within 30 days
|
|
COPD Symptoms option 1
Time Frame: Within 30 days
|
Evaluation of COPD symptoms using COPD Assessment Test (CAT)
|
Within 30 days
|
|
COPD Symptoms option 2
Time Frame: Within 30 days
|
Evaluation of COPD symptoms using the modified medical Research Council Scale (mmRC) [Scale = 0 to 4; 0 (better) = Breathlessness only on strenuous exercise; 4 (worse)= too breathless to leave the house or breathless when dressing or undressing]
|
Within 30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Valerie G Press, MD, MPH, University of Chicago
Publications and helpful links
General Publications
- Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009 Apr 2;360(14):1418-28. doi: 10.1056/NEJMsa0803563. Erratum In: N Engl J Med. 2011 Apr 21;364(16):1582.
- Naylor MD, Aiken LH, Kurtzman ET, Olds DM, Hirschman KB. The care span: The importance of transitional care in achieving health reform. Health Aff (Millwood). 2011 Apr;30(4):746-54. doi: 10.1377/hlthaff.2011.0041.
- Locke ER, Thomas RM, Woo DM, Nguyen EHK, Tamanaha BK, Press VG, Reiber GE, Kaboli PJ, Fan VS. Using Video Telehealth to Facilitate Inhaler Training in Rural Patients with Obstructive Lung Disease. Telemed J E Health. 2019 Mar;25(3):230-236. doi: 10.1089/tmj.2017.0330. Epub 2018 Jul 17.
- Thomas RM, Locke ER, Woo DM, Nguyen EHK, Press VG, Layouni TA, Trittschuh EH, Reiber GE, Fan VS. Inhaler Training Delivered by Internet-Based Home Videoconferencing Improves Technique and Quality of Life. Respir Care. 2017 Nov;62(11):1412-1422. doi: 10.4187/respcare.05445. Epub 2017 Jul 18.
- Press VG, Au DH, Bourbeau J, Dransfield MT, Gershon AS, Krishnan JA, Mularski RA, Sciurba FC, Sullivan J, Feemster LC. Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2019 Feb;16(2):161-170. doi: 10.1513/AnnalsATS.201811-755WS.
- Ramadurai D, Lee CT, Traeger L, Pucci G, Jackson-Sagredo A, Shah S, Abraham J, Arora VM, Press VG. Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients (TELE-TOC): a study protocol for a type II hybrid effectiveness-implementation randomised, pragmatic clinical trial of a pharmacist-led intervention. BMJ Open. 2025 Nov 4;15(11):e105521. doi: 10.1136/bmjopen-2025-105521.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB21-1325
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.